These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26523333)

  • 1. Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery.
    Huchet QA; Kuhn B; Wagner B; Kratochwil NA; Fischer H; Kansy M; Zimmerli D; Carreira EM; Müller K
    J Med Chem; 2015 Nov; 58(22):9041-60. PubMed ID: 26523333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The strength of weak interactions: aromatic fluorine in drug design.
    Dimagno SG; Sun H
    Curr Top Med Chem; 2006; 6(14):1473-82. PubMed ID: 16918463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gem-Difluorination on the Key Physicochemical Properties Relevant to Medicinal Chemistry: The Case of Functionalized Cycloalkanes.
    Holovach S; Melnykov KP; Skreminskiy A; Herasymchuk M; Tavlui O; Aloshyn D; Borysko P; Rozhenko AB; Ryabukhin SV; Volochnyuk DM; Grygorenko OO
    Chemistry; 2022 Apr; 28(19):e202200331. PubMed ID: 35147261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Partially Fluorinated N-Alkyl-Substituted Piperidine-2-carboxamides on Pharmacologically Relevant Properties.
    Vorberg R; Trapp N; Zimmerli D; Wagner B; Fischer H; Kratochwil NA; Kansy M; Carreira EM; Müller K
    ChemMedChem; 2016 Oct; 11(19):2216-2239. PubMed ID: 27629993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective fluorination in drug design and development: an overview of biochemical rationales.
    Kirk KL
    Curr Top Med Chem; 2006; 6(14):1447-56. PubMed ID: 16918460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxetanes in drug discovery: structural and synthetic insights.
    Wuitschik G; Carreira EM; Wagner B; Fischer H; Parrilla I; Schuler F; Rogers-Evans M; Müller K
    J Med Chem; 2010 Apr; 53(8):3227-46. PubMed ID: 20349959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fluoroalkyl Substituents on the Physicochemical Properties of Saturated Heterocyclic Amines.
    Melnykov KP; Tavlui O; Skreminskiy A; Kuchkovska YO; Grygorenko OO
    Chemistry; 2022 Oct; 28(55):e202201601. PubMed ID: 35699162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated compounds in medicinal chemistry: recent applications, synthetic advances and matched-pair analyses.
    Barnes-Seeman D; Beck J; Springer C
    Curr Top Med Chem; 2014; 14(7):855-64. PubMed ID: 24484427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico physicochemical parameter predictions.
    Wenlock MC; Barton P
    Mol Pharm; 2013 Apr; 10(4):1224-35. PubMed ID: 23305561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fluorine substitution on the physicochemical properties and the analgesic activity of paracetamol.
    Barnard S; Storr RC; O'Neill PM; Park BK
    J Pharm Pharmacol; 1993 Aug; 45(8):736-44. PubMed ID: 7901373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorination methods for drug discovery and development.
    Richardson P
    Expert Opin Drug Discov; 2016 Oct; 11(10):983-99. PubMed ID: 27548817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups.
    Müller K
    Chimia (Aarau); 2014; 68(6):356-62. PubMed ID: 25198745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity.
    Murphy CD; Sandford G
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):589-99. PubMed ID: 25728479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorinated Cycloalkyl Building Blocks for Drug Discovery.
    Grygorenko OO; Melnykov KP; Holovach S; Demchuk O
    ChemMedChem; 2022 Nov; 17(21):e202200365. PubMed ID: 36031924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorination methods in drug discovery.
    Yerien DE; Bonesi S; Postigo A
    Org Biomol Chem; 2016 Sep; 14(36):8398-427. PubMed ID: 27506398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine in drug design: a case study with fluoroanisoles.
    Xing L; Blakemore DC; Narayanan A; Unwalla R; Lovering F; Denny RA; Zhou H; Bunnage ME
    ChemMedChem; 2015 Apr; 10(4):715-26. PubMed ID: 25755132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorinated scaffolds for antimalarial drug discovery.
    Upadhyay C; Chaudhary M; De Oliveira RN; Borbas A; Kempaiah P; Singh P; Rathi B
    Expert Opin Drug Discov; 2020 Jun; 15(6):705-718. PubMed ID: 32202162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
    Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
    J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tert-butyl isosteres: case studies of physicochemical and pharmacokinetic properties, efficacies, and activities.
    Westphal MV; Wolfstädter BT; Plancher JM; Gatfield J; Carreira EM
    ChemMedChem; 2015 Mar; 10(3):461-9. PubMed ID: 25630804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.